Menu
  • Join
  • Login
  • Contact
 

Search abstracts


EFFICACY AND SAFETY OF SAXAGLIPTIN、SITAGLIPTIN PLUS METFORMIN FIXED-DOSE COMBINATION AS ADD-ON THERAPY WITH DUAL COMBINATION OF TRADITIONAL ORAL HYPOGLYCEMIC AGENTS IN TYPE 2 DIABETES MELLITUS

  • At: 2015 FIP Congress in Düsseldorf (Germany)
  • Type: Poster
  • By: HU, Chun-Liang (Tainan Municipal Hospital, pharmacy, Tainan, China Taiwan)
  • Co-author(s): Chun-Liang Hu
  • Abstract:

    Less data confirm what kind of dipeptidyl peptidase-4 inhibitors/Metformin fixed-dose combination (DPP4I/Met FDC) medicine is more effective and safe when type 2 diabetes mellitus (T2DM) patients need additional medicines to meet glycemic targets.

    We retrospectively screened the data of T2DM patients who received Saxagliptin/Metformin 5/1000mg

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses